Active — Not RecruitingNot Applicable

Wireless Irradiance SEnsors During Neonatal Phototherapy

Canada9 participantsStarted 2025-07-10

Plain-language summary

Bilisensors are devices designed to measure the cumulative dose of phototherapy administered to neonates undergoing treatment for hyperbilirubinemia. The current standard of care typically involves intermittent spot measurements once a day using a handheld dosimeter that may give variable estimations. In contrast, bilisensors may enable continuous, real-time monitoring of light exposure, helping to know the total phototherapy dose received by the infant.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants must be admitted to the Montreal Children's Hospital (MCH) Neonatal Intensive Care Unit (NICU) * Under phototherapy as clinically indicated * Diagnosis of indirect hyperbilirubinemia * Weight of \>1000g at time of enrollment Exclusion Criteria: * Any abnormal skin conditions (example: extreme dryness, desquamation, congenital skin disorders, etc.) * Diagnosis of direct hyperbilirubinemia * Weight of \<1000g at time of enrollment * Any baby or family deemed ineligible (ex. too much stress, too unstable) by the clinical care team

What they're measuring

Light Intensity

Timeframe: 3 Hours

Trial details

NCT IDNCT07057635

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-10

View on ClinicalTrials.gov More Neonatal Hyperbilirubinemia trials